As of August 28, 2026, Cyclerion Therapeutics, Inc. (CYCN) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Cyclerion Therapeutics, Inc. has a market capitalization of $13.64M, 4.68M shares outstanding, 10 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 34%
💰 Capital Raise
model 55%
• Critical: only 1.6 months cash remaining
🔄 Reverse Split
model est. 15%
• Only 2 months cash — financial pressure
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (65/100)
Market Data
Market Cap$13.64M
Shares Outstanding4.68M
Float3.58M
Cash$1.39M
Debt$3.50M
Short InterestN/A
Institutional Holdings
10 institutional holders · 295.2K shares
#1
Siren, L.L.C.
115.6K shares
#2
Geode Capital Management, LLC
43.3K shares
#3
Two Sigma Investments, LP
41.6K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest45.0K
Days to Cover2.6
% of Float1.3%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track CYCN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CYCN — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for CYCN
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.